Related content

Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1–specific cellular immune responses in vivo

By Ye Jing   Chen Guang-Sheng   Song Hong-Ping   Li Zeng-Shan   Huang Ya-Yu   Qu Ping   Sun Yu-Jing   Zhang Xiu-Min   Sui Yan-Fang  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 9, 2004-09 ,pp. : 825-834

Springer Publishing Company

Access to resources Recommend Favorite

The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route

By Ge Wei  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 2, 2009-02 ,pp. : 201-208

Springer Publishing Company

Access to resources Recommend Favorite

Serum MAGE-4 Protein in Ovarian Cancer Patients

By Kawagoe H.   Yamada A.   Matsumoto H.   Ito M.   Ushijima K.   Nishida T.   Yakushiji M.   Itoh K.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 336-339

Elsevier

Access to resources Recommend Favorite

Evaluation of MAGE A1 in oral squamous cell carcinoma

By            

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1843-1848

Spandidos Publications

Access to resources Recommend Favorite

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report

By Marchand M.   Punt C.J.A.   Aamdal S.   Escudier B.   Kruit W.H.J.   Keilholz U.   Hakansson L.   van Baren N.   Humblet Y.   Mulders P.   Avril M.-F.   Eggermont A.M.M.   Scheibenbogen C.   Uiters J.   Wanders J.   Delire M.   Boon T.   Stoter G.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 70-77

Elsevier

Access to resources Recommend Favorite